Obesity drugs shed niche tag, set to gain more weight in India pharma

India's obesity drug market is experiencing rapid growth, driven by rising lifestyle diseases and the launch of blockbuster therapies. The impending entry of low-cost generics is set to further accelerate this expansion, making treatments more accessible to a wider population beyond urban elites.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4v5Ooz6
via IFTTT